These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11769519)

  • 1. [New clinical laboratory tests for urinary tract diseases].
    Kimura H; Yoshida H
    Nihon Naika Gakkai Zasshi; 2001 Nov; 90(11):2219-24. PubMed ID: 11769519
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of plasma total cholesterol, free cholesterol and esterified cholesterol levels].
    Taki M; Teramoto T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():10-3. PubMed ID: 15658250
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma cystatin C for estimating residual GFR (rGFR) in dialysis patients.
    Tidman M; Sjöström P; Jones I
    Nephrol Dial Transplant; 2008 Mar; 23(3):1072-3; author reply 1073. PubMed ID: 17984103
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cystatin C: current step and future prospects].
    Séronie-Vivien S; Delanaye P; Pieroni L; Mariat C; Froissart M; Cristol JP;
    Ann Biol Clin (Paris); 2008; 66(3):301-23. PubMed ID: 18558570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cystatin C].
    Hirata A; Igarashi M; Tominaga M
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():515-9. PubMed ID: 12355800
    [No Abstract]   [Full Text] [Related]  

  • 6. Can serial measurements of cystatin C accurately detect early renal function decline?
    Herget-Rosenthal S
    Nat Clin Pract Nephrol; 2005 Dec; 1(2):68-9. PubMed ID: 16932367
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of the anesthesiologist in secondary hyperparathyroidism].
    Alessi R; Mularo A; Sansone A
    G Chir; 2010; 31(6-7):339-40. PubMed ID: 20646388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C and the risk of death.
    Perkins BA; Nelson RG; Krolewski AS
    N Engl J Med; 2005 Aug; 353(8):842-4; author reply 842-4. PubMed ID: 16124125
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
    Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
    [No Abstract]   [Full Text] [Related]  

  • 10. [Usefulness of serum cystatin C for the diagnosis of impaired renal function].
    Oyabu C; Hayashi N; Sugiyama D; Umezu M; Mukai M; Kawano S; Kumagai S
    Rinsho Byori; 2006 Dec; 54(12):1204-8. PubMed ID: 17265892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cystatin C as a marker of glomerular filtration rate].
    Piwowar A; Warwas M
    Postepy Hig Med Dosw; 2001; 55(5):687-98. PubMed ID: 11795203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of a new PTH assay (the comparison between whole-PTH and intact-PTH assay)].
    Ito N; Fukumoto S
    Clin Calcium; 2004 Sep; 14(9):55-6. PubMed ID: 15577110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease in the elderly--how to assess risk.
    Stevens LA; Levey AS
    N Engl J Med; 2005 May; 352(20):2122-4. PubMed ID: 15901867
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
    Zucchi C
    Minerva Med; 1985 Mar; 76(9-10):397-401. PubMed ID: 3982697
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
    Karlsson SL; Indridason OS; Franzson L; Sigurdsson G
    Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic triglyceride lipase (HTGL)].
    Kinoshita M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():79-81. PubMed ID: 15658267
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis.
    Samouilidou EC; Grapsa E
    Ren Fail; 2008; 30(7):711-5. PubMed ID: 18704820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of renal function in kidney donors using serum cystatin C and beta(2)-microglobulin.
    John GT; Fleming JJ; Talaulikar GS; Selvakumar R; Thomas PP; Jacob CK
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):656-8. PubMed ID: 14629804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of parathyroid hormone gene polymorphism on cardiovascular mortality].
    Tsujimoto Y; Tabata T; Inoue T; Tahara H; Shoji T; Shinohara K; Inaba M; Nishizawa Y
    Clin Calcium; 2005 Sep; 15 Suppl 1():106-9; discussion 109. PubMed ID: 16272640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystatin C measurement: improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates?
    Bostom AG; Dworkin LD
    Am J Kidney Dis; 2000 Jul; 36(1):205-7. PubMed ID: 10873893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.